We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Able Labs Proposes Consent Decree To Resolve Long List of cGMP Violations
Able Labs Proposes Consent Decree To Resolve Long List of cGMP Violations
August 1, 2005
Embattled generic drugmaker Able Laboratories, which in May voluntarily recalled its entire product line because of quality problems, is hoping to restart its operations under a consent decree agreement it has proposed to the FDA.